เอกสารอ้างอิง
[1]. Haines ST, Zeolla M, Witt DM. Venous thromboembolism. In. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach. 9th ed. Appleton&Lange: Stamford; 2014.
[2]. Konstantinides SV, Meyer G. The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism. Eur. Heart J. 2019 Nov. 1;40(42):3453-3455.
[3]. Rees M, Williams TJ. Pulmonary embolism: Assessment and management. Australian Family Physician 2005:34:555-61.
[4]. Lexicomp, Inc. enoxaparin: Drug information. In:Post TW, ed.UpToDate.Waltham: UpToDate; 2017 (Accessed on Dec. 11, 2022).
[5]. Lexicomp, Inc. apixaban: Drug information. In:Post TW, ed.UpToDate.Waltham: UpToDate; 2017 (Accessed on Dec. 11, 2022).
[6]. Barrett YC, Wang J, Song Y, Pursley J, Wastall P, Wright R, Lacreta F, Frost C. A randomised assessment of the pharmacokinetic, pharmacodynamic and safety interaction between apixaban and enoxaparin in healthy subjects. Thromb Haemost. 2012 May.;107(5):916-24.